Immutep Limited

Ord Minnett View

You need to become a client or login to see Forsyth Barr’s current view.

Recent research View all research

About Immutep Limited

Prima BioMed Ltd (PRR) is a global biotechnology company headquartered in Australia. PRR focuses on personalised bio-therapeutic products for cancer. Its lead product is CVac, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients who are in remission. PRR also develops an oral vaccine against Human Papilloma Virus (HPV).

Forsyth Barr Analyst

Share price performance

All stock prices and news delayed 20 minutes

11:25 December 19th 2018 NZDT

0.03 0.0%

0.03 Buy

0.03 Sell

Last --

Open --

High --

Low --

Volume -

Turnover -

Most recent trades All trades for the day

Time Price Volume Value

Latest Immutep Limited research

Today's trades

Trade Number Time Price Volume Value

Latest Immutep Limited news

There is currently no news available.

If you're new to investing or just have a question please call us: 0800 367 227